For the quarter ending 2025-12-31, ANEB has $9,421,997 in assets. $1,485,646 in debts. $9,041,570 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 9,041,570 | 10,354,773 | 11,627,849 | |
| Grant receivable | 56,783 | 9,825 | 73,218 | |
| Prepaid expenses | 175,413 | 170,771 | 261,439 | |
| Total current assets | 9,273,766 | 10,535,369 | 11,962,506 | |
| Loan commitment fees | 148,231 | 165,670 | 183,110 | |
| Total assets | 9,421,997 | 10,701,039 | 12,145,616 | |
| Accounts payable | 554,862 | 607,539 | 224,175 | |
| Accrued expenses | 930,784 | 356,282 | 263,513 | |
| Total liabilities | 1,485,646 | 963,821 | 487,688 | |
| Common stock, 0.001 par value 75,000,000 shares authorized and 41,084,731 shares issued and outstanding at december 31, 2025 and june 30, 2025 | 41,086 | 41,086 | 41,086 | |
| Additional paid-in capital | 85,941,523 | 85,742,993 | 85,505,349 | |
| Accumulated deficit | -78,046,258 | -76,046,861 | -73,888,507 | |
| Total stockholders equity | 7,936,351 | 9,737,218 | 11,657,928 | |
| Total liabilities and stockholders equity | 9,421,997 | 10,701,039 | 12,145,616 | |
Anebulo Pharmaceuticals, Inc. (ANEB)
Anebulo Pharmaceuticals, Inc. (ANEB)